Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




RAPIDComm Data Management System Receives Major Upgrade

By LabMedica International staff writers
Posted on 06 Sep 2016
Siemens Healthineers (Erlangen, Germany) has released a major upgrade to the RAPIDComm Data Management System, an informatics solution used to centrally manage in vitro diagnostics (IVD) analyzers and operators at the point-of-care (POC).

The RAPIDComm System is a total solution for POC data management, including cardiac support. More...
The system connects to the Stratus CS 200 Acute Care Diagnostic System, which provides increased IVD connections, including time synchronization with the CLINITEK Status Connect System to automatically synchronize instruments daily for consistency across the POC ecosystem. Secure access ensures the POC devices are online, operational, and properly maintained, with immediate oversight and control.

Other performance and productivity features include a configurable backup utility that aids customers with remote database configurations to directly manage their backup activities; generate material use reports for diabetes and urinalysis assist in inventory management; and monitor device status alerts, email notifications, and operator comments. System features such as the lock-out component--which prohibits operators not yet certified to use the equipment from running tests--are designed to improve compliance practices and enhance patient safety.

“Point-of-care coordinators face tremendous workflow challenges when implementing and managing POC testing programs,” said Peter Koerte, president of POC at Siemens Healthineers. “They are typically responsible for managing the testing done at dozens of locations on hundreds of devices and by thousands of operators, all while ensuring results are delivered quickly and reliably, and that compliance requirements of the laboratory remain satisfied.”

The RAPIDComm Data Management System also offers online competency based training for staff, including training record management, workgroup management, personalized learning plans, e-quizzes and qualification plans, an interface to the personalized education plan (PEP) administrator, and proficiency testing.

Related Links:
Siemens Healthineers


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.